Novo CEO Expects Patients to Stay on Wegovy Longer Than Older Weight Loss Drugs Novo CEO Expects Patients to Stay on Wegovy Longer Than Older Weight Loss Drugs

Novo Nordisk ' s CEO said on Tuesday he expects patients will stick with the company ' s popular obesity drug Wegovy for far longer than those using older...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology Source Type: news